The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1963, 90: 697-702.
Copyright © 1963 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fiock, M. A.
Right arrow Articles by Gearinger, N. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiock, M. A.
Right arrow Articles by Gearinger, N. F.

Studies on Immunity to Toxins of Clostridium Botulinum

IX. Immunologic Response of Man to Purified Pentavalent ABCDE Botulinum Toxoid

Mary A. Fiock, Matteo A. Cardella and Naomi F. Gearinger

From the United States Army Biological Laboratories, Fort Detrick, Frederick, Maryland

Abstract

Purified toxins of Clostridium botulinum types A, B, C, D and E were converted to toxoids and adsorbed on aluminum phosphate; four preparations of pentavalent toxoid were investigated in groups of 15 to 30 volunteers. Each pentavalent product contained 1.7 Lf of type A, 0.54 Lf of type B, 50,000 LD50 equivalents of type C, 4 Lf of type D, and 0.5 Lf or 100,000 LD50 equivalents of type E toxoid/ml. All flocculation potencies are referred to standard antitoxins prepared by the Microbiological Research Establishment, Porton, England. Doses of the first preparation of pentavalent toxoid (0.5 ml) were administered subcutaneously at 0, 2 and 10 weeks; the other preparations were given in the same way except that a 0-2-12 week schedule was used. Booster doses of 0.5 ml were given 1 year after the initial injection. Serum antitoxin titers of individuals were determined 12 to 14 and 52 weeks after the initial injection, and again 8 weeks after the booster, by neutralization titrations in mice. After the initial series of injections a considerable proportion of the individuals developed antitoxin titers for all or most of the five toxins; the proportion of satisfactory titers varied with the type and also with the preparation. Good booster responses were obtained with all preparations, and antitoxin titers to each of the five types were found in 86 to 100% of the individuals immunized. Stability studies with one preparation showed that the toxoids retained considerable antigenicity for at least 16 months at 4°C.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
M. R. Baldwin, W. H. Tepp, A. Przedpelski, C. L. Pier, M. Bradshaw, E. A. Johnson, and J. T. Barbieri
Subunit Vaccine against the Seven Serotypes of Botulism
Infect. Immun., March 1, 2008; 76(3): 1314 - 1318.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1963 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1963 by The American Association of Immunologists, Inc. All rights reserved.